Shift Bioscience
Cambridge, England, United Kingdom · Artificial Intelligence, Biotechnology, Health Care
Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling con
Key facts
- Headquarters
- Cambridge, England, United Kingdom
- Employees
- 16
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- www.shiftbioscience.com
- Company page
Recent activity at Shift Bioscience
- : Shift Bioscience Expands into North America with New AI-Powered Virtual Cell Development Team in Toronto.
- : Shift Bioscience Secures $16 Million to Enhance AI Cell Simulation Platform for Age-Related Disease Treatments
- : Shift Bioscience raised $16M in a seed funding round led by Business Growth Fund to develop its AI cell simulation platform aimed at reversing age-related illnesses.
Shift Bioscience funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2024 | Seed | $16.0M |
Leadership
- Brendan Swain, Chief Scientific Officer
- Katsiaryna Maskalenka, Head of Research and Development
- Henry Miller, Machine Learning Engineer
- Daniel Ives, Founder
Verified email and direct lines for Shift Bioscience’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Shift Bioscience in the news
Companies similar to Shift Bioscience
- Graph Therapeutics · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Newronika · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Change Agents Corporation. · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Pathos AI · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
- Synaptogenix · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Therapeutics
About Shift Bioscience: questions and answers
What does Shift Bioscience do?
Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling con
Where is Shift Bioscience headquartered?
Shift Bioscience is headquartered in Cambridge, England, United Kingdom.
How many employees does Shift Bioscience have?
Shift Bioscience has about 16 employees.
Has Shift Bioscience raised funding?
Yes. Fundz has recorded 1 funding event for Shift Bioscience. The most recent, Seed of $16.0M, was in Oct 2024.
Who leads Shift Bioscience?
Daniel Ives is a Founder at Shift Bioscience.
What is the latest news on Shift Bioscience?
On Feb 18, 2025, Shift Bioscience Expands into North America with New AI-Powered Virtual Cell Development Team in Toronto.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy